• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Oral cholera vaccine moderately effective in reducing the burden of severely dehydrating diarrhea

byMelissa McCoyandXiaozhou Liu
July 11, 2015
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this cluster-randomized, open-label trial, a whole-cell cholera vaccine demonstrated moderate effectiveness of around 40% in protecting against severely dehydrating cholera.

2. The vaccine was well tolerated with no reported vaccine-related serious adverse events. Behavioral change had a small augmenting effect to the vaccine efficacy.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Cholera is a diarrheal disease that can cause severe dehydration, and as such poses a significant threat in low-income countries. This randomized, open-label study assessed the effectiveness and feasibility of oral cholera vaccine against severely dehydrating cholera in a real-life urban setting through government services in Bangladesh. Participants were assigned to a vaccination-only group, a vaccination and behavioral intervention group, or a no-intervention group. The vaccination-only group received 2 standard doses of oral cholera vaccine and the vaccination and behavioral intervention group received 2 standard doses of vaccine and additionally participated in a program promoting hand-washing and drinking water treatment with chlorine. The primary outcome for this study was protective effectiveness against severely dehydrating cholera during 2-year follow up. Overall protective effectiveness was 37% in the vaccination only group and 45% in the vaccination and behavioral change group. A strength of this study is that it demonstrated effectiveness in real life application with a large trial population. A potential weakness is that a placebo was not used in the control group and thereby prevented masking of the study.

The study was funded by Bill & Melinda Gates Foundation.

Click to read the study in The Lancet

Relevant Reading: 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial

RELATED REPORTS

National survey reports parental views on COVID-19 vaccination in children

Tdap vaccine during pregnancy not linked to adverse childhood health outcomes

#VisualAbstract: Special Report: Vaccines in Development- Johnson & Johnson vaccine as another frontrunner

In-Depth [randomized controlled trial]: This cluster-randomized open-label trial aimed to analyze the acceptability, programmatic feasibility, and protective effectiveness of oral cholera vaccine against severely dehydrating cholera in an urban setting in Bangladesh with high rates of cholera. 267,270 participants were randomly assigned (1:1:1) to either a vaccination-only group that received 2 standard doses of oral cholera vaccine, a vaccination and behavioral intervention group that received 2 standard doses of the vaccine, plus participating in a program promoting hand-washing and drinking water treatment with chlorine, or a no-intervention group.

The primary outcome was protective effectiveness against severely dehydrating cholera during 2-year follow up for all individuals present after the second dose. Vaccine coverage was 65% in the vaccination-only group and 66% in the vaccination and behavioral intervention group. Overall, protective effectiveness was 37% (95% CI lower bound 18%; p=0.0024) for the vaccine-only group and 45% (95% CI lower bound 24%; p=0.0011) in the vaccination and behavioral intervention group. The occurrence of cholera was not significantly between the vaccination-only group and the vaccination and behavioral change group (p=0.50). The vaccine showed no protection against enterotoxigenic E coli diarrhea (protective effectiveness 1%, 95% CI lower bound -23%; p=0.46). There were no reported serious adverse events. Most common non-serious adverse events included acute watery diarrhea, vomiting, abdominal pain, and fever.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: choleravaccines
Previous Post

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

Next Post

Undiagnosed hypothyroidism associated with adverse pregnancy outcomes

RelatedReports

Compliance-linked incentives increase infant immunizations rates in rural India
Infectious Disease

National survey reports parental views on COVID-19 vaccination in children

September 14, 2021
Compliance-linked incentives increase infant immunizations rates in rural India
Infectious Disease

Tdap vaccine during pregnancy not linked to adverse childhood health outcomes

April 19, 2021
#VisualAbstract: Cabotegravir plus rilpivirine given every 8 weeks is non-inferior to every 4 weeks for maintenance of HIV-1 viral suppression
StudyGraphics

#VisualAbstract: Special Report: Vaccines in Development- Johnson & Johnson vaccine as another frontrunner

January 5, 2021
Compliance-linked incentives increase infant immunizations rates in rural India
Infectious Disease

Success rates and timelines of recently studied viral vaccine candidates

December 7, 2020
Next Post
Undiagnosed hypothyroidism associated with adverse pregnancy outcomes

Undiagnosed hypothyroidism associated with adverse pregnancy outcomes

Percutaneous bleomycin foam effectively treats venous malformations

Percutaneous bleomycin foam effectively treats venous malformations

Rate of occult fracture evaluations for child abuse insufficient

Rate of occult fracture evaluations for child abuse insufficient

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early exposure to allergenic foods may reduce incidence of long-term food allergy
  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.